Innovative Immunotherapy Trials for Lung Cancer

This chapter delves into a groundbreaking clinical trial at Johns Hopkins exploring the efficacy of immunotherapy combined with chemotherapy for lung cancer patients. It reveals promising results, with a notable percentage of patients experiencing no residual cancer after treatment, suggesting enhanced survival outcomes.